Delivering Advanced Therapeutics
GRANT TO ASSESS CriticalSorb NOVEL ABSORPTION ENHANCER FOR NASAL DELIVERY
Critical Pharmaceuticals Wins Grant to Assess Novel Absorption Enhancer for Nasal Drug Delivery.
Critical Pharmaceuticals has been awarded a £33000 grant by the bioKneX Industrial Partnership Scheme to help it assess the potential of a recent discovery made at the company. The scheme was set up to help businesses access the expertise and facilities within universities in the East Midlands. Critical Pharmaceuticals will use the money to pay for research to be performed at the University of Nottingham which will assess the effectiveness and tolerability of a novel absorption enhancer that was discovered by the company last year that allows drugs such as insulin and human growth hormone to be given to patients by a nasal spray.
Dr Andy Lewis, Head of Formulation Development said, “This discovery is incredibly exciting because it opens up the possibility of developing nasal sprays for drugs that currently need to be injected, often several times a week. However before we can develop a product we need to carry out extensive testing and this award will help us begin this process. We are tremendously pleased to receive this award which helps us to not only work with Dr Snow Stolnick - one of the world leaders in the field - but also have access to the state of the art facilities at the School of Pharmacy at the University of Nottingham.”